S
Sunbloom Proteins
We make vegetable foods attractive even for omnivores
About Sunbloom Proteins
Sunbloom is a German-based company specializing in the development and production of high-quality sunflower protein, aimed at enhancing the nutritional value of vegan and vegetarian foods. The company operates within the food industry, focusing on global food security and healthier dietary options. Sunbloom's core product is sunflower protein, which is developed and patented in Germany and produced across Europe. This protein serves as a key ingredient in various food products, offering a sustainable and nutritious alternative to traditional protein sources.
Sunbloom collaborates with established companies like Zentis and Ehrmann, leveraging their extensive networks and expertise in the food industry. This partnership not only enhances Sunbloom's market reach but also ensures the high quality and reliability of its products. The company's business model revolves around B2B (business-to-business) transactions, where it supplies sunflower protein to food manufacturers and other enterprises in the food sector. Revenue is generated through the sale of these protein products, which are in high demand due to the growing trend towards plant-based diets.
Sunbloom's target clients include food manufacturers, health-conscious consumers, and businesses looking to incorporate sustainable and nutritious ingredients into their products. The company is well-positioned in the European market but also aims to expand its reach globally, addressing the increasing demand for plant-based protein solutions.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2017
- Headquarters
- Munich, Germany
- Employees
- 17
- Open positions
- None listed
- Dealroom signal
- 76.7/100
- Industry
- Food
- Sub-industry
- Innovative Food
- Sector
- Food, Plant-Based, Spinout, Alternative Protein, Sustainable Development Goals, Dairy Substitute, Ingredient, Enabler of Alternative Proteins, Climate Tech, Hard Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Apr 2023 | $0 | — | Avril | ↗ |
| SERIES AOther financing | Jan 2019 | $11M | $44M | Zentis | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Sunbloom Proteins is 80 monthly website visits, down 95.6% over the last three months. Sunbloom Proteins's team grew 41.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Zentis
Other known investors3 additional known investors
Avril
Fraunhofer Society - Fraunhofer Gesellschaft
Fraunhofer Venture
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Sunbloom Proteins on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sunbloom Proteins’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







